EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting RANKL Prevents Bone Loss, Improves Muscle Function and Extends Lifespan in Progeroid Mice

Sandra Freitas-Rodríguez iD, Alejandra Valle-Cao iD, Francisco Rodríguez iD, Manuel Fernández-Sanjurjo, Benjamín Fernández-García iD, Vanessa Loredo, María Teresa Fernández-García, Carmen Fiuza-Luces iD, Alejandro Lucia, Carlos López-Otín, Alejandro López-Soto iD, Alicia R Folgueras iD

Aging Cell · 2026-08 · 25 (8)

DOI: 10.1111/acel.70655 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, online erschienen am 09.08.2026. Verfasst von Sandra Freitas-Rodríguez und 11 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Unive…. Hauptthemen laut MEDLINE: RANK Ligand, Progeria, Longevity, Bone Resorption. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación, Agencia de Ciencia, Competitividad Empresarial e Innovación Asturiana-SEKUENS, Consejería de Ciencia, Innovación y Universidad del Gobierno del Principado de Asturias.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hutchinson‐Gilford progeria syndrome (HGPS) is a rare genetic disorder characterized by the early development of pathological features associated with aging, ultimately leading to premature death. HGPS primarily affects tissues of mesenchymal origin, as evidenced by the clinical manifestations characteristic of this premature aging disorder, including, but not limited to, osteoporosis, muscle wasting, lipodystrophy, and cardiovascular disease. In this study, we used preclinical mouse models and both genetic and translational approaches to investigate whether an antiresorptive strategy, based on RANKL targeting, ameliorated the bone loss phenotype of progeroid mice. Here we show that osteocyte‐derived RANKL deletion in the Zmpste24 −/− mouse model of HGPS reverted bone loss in both long bones and vertebrae. These mice also exhibited increased grip strength and improved endurance capacity. Furthermore, Zmpste24 −/− mice showed increased survival upon osteocyte‐specific RANKL deletion. Notably, the use of a translational approach based on the administration of a neutralizing antibody against RANKL also restored bone mass, reduced muscle fibrosis, and extended the lifespan of Zmpste24 −/− mice. Altogether, these findings support that targeting RANKL exerts a beneficial effect on both osseous and extra‐osseous phenotypes of HGPS, suggesting the potential of this therapeutic approach to explore in the treatment of this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RANK LigandProgeriaLongevityBone ResorptionAnimalsMiceMice, KnockoutMetalloendopeptidasesDisease Models, AnimalMembrane Proteins

Stichwörter der Autor:innen

HGPSRANKLagingbone lossdenosumabprogeria

Substanzen

RANK LigandZmpste24 protein, mouseTnfsf11 protein, mouseMetalloendopeptidasesMembrane Proteins

Autor:innen und Institutionen

  • Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Universidad de Oviedo, Oviedo, Spain.
  • Unidad de Transgénicos, Servicios Científico-Técnicos. Bioterio, Universidad de Oviedo, Oviedo, Spain.
  • Departamento de Biología Funcional, Área de Fisiología, Facultad de Medicina, Universidad de Oviedo, Oviedo, Spain.
  • Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
  • Departamento de Morfología y Biología Celular, Facultad de Medicina, Universidad de Oviedo, Oviedo, Spain.
  • Departamento de Medicina, Área de Pediatría, Facultad de Medicina, Universidad de Oviedo, Oviedo, Spain.

ORCID-Profile: Sandra Freitas-Rodríguez, Alejandra Valle-Cao, Francisco Rodríguez, Benjamín Fernández-García, Carmen Fiuza-Luces, Alejandro López-Soto, Alicia R Folgueras

Förderung

  • Ministerio de Ciencia e Innovación
  • Agencia de Ciencia, Competitividad Empresarial e Innovación Asturiana-SEKUENS
  • Consejería de Ciencia, Innovación y Universidad del Gobierno del Principado de Asturias
  • European Research Council

Zitieren

APA

Freitas-Rodríguez, S., Valle-Cao, A., Rodríguez, F., Fernández-Sanjurjo, M., Fernández-García, B., Loredo, V., Fernández-García, M. T., Fiuza-Luces, C., Lucia, A., López-Otín, C., López-Soto, A., & Folgueras, A. R. (2026). Targeting RANKL Prevents Bone Loss, Improves Muscle Function and Extends Lifespan in Progeroid Mice. Aging Cell, 25(8). https://doi.org/10.1111/acel.70655

Vancouver

Freitas-Rodríguez S, Valle-Cao A, Rodríguez F, Fernández-Sanjurjo M, Fernández-García B, Loredo V, et al. Targeting RANKL Prevents Bone Loss, Improves Muscle Function and Extends Lifespan in Progeroid Mice. Aging Cell. 2026;25(8). doi:10.1111/acel.70655

BibTeX
@article{FreitasRodrguez2026,
  author = {Freitas-Rodríguez, Sandra and Valle-Cao, Alejandra and Rodríguez, Francisco and Fernández-Sanjurjo, Manuel and Fernández-García, Benjamín and Loredo, Vanessa and Fernández-García, María Teresa and Fiuza-Luces, Carmen and Lucia, Alejandro and López-Otín, Carlos and López-Soto, Alejandro and Folgueras, Alicia R},
  title = {Targeting RANKL Prevents Bone Loss, Improves Muscle Function and Extends Lifespan in Progeroid Mice},
  journal = {Aging Cell},
  year = {2026},
  volume = {25},
  number = {8},
  doi = {10.1111/acel.70655}
}
Kostenlos starten →